Thomas Morrow, MD

03/10/2016

Part one of this two-part series reviews the history, drivers, and regulatory changes that have allowed telemedicine to flourish.

Part one of this two-part series...

03/10/2016

First Report Managed Care

Viewpoint

05/22/2017

Tom Morrow, MD, discusses the cost of PCSK9 Inhibitors and how they impacted patient response rates in a recent study.

Tom Morrow, MD, discusses the...

05/22/2017

First Report Managed Care

November 13 ⁠–⁠ November 16

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1